SCHEMBL8640342

SCHEMBL8640342

Fc1ccc(-n2cc(C3CCNCC3)c3cc(F)ccc32)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.81
HTR6 P50406 4/20 0.59
DRD2 P14416 9/20 0.53
HTR1B P28222 2/20 0.52
HTR2C P28335 2/20 0.51
HRH1 P35367 2/20 0.51
MLNR O43193 1/20 0.51
CACNA1F O60840 1/20 0.51
NR1I2 O75469 1/20 0.51
ABCB11 O95342 1/20 0.51
ABCB1 P08183 1/20 0.51
ADRB1 P08588 1/20 0.51
HTR1A P08908 1/20 0.51
ADRA2A P08913 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
CHRM1 P11229 1/20 0.51
ADRA2B P18089 1/20 0.51
ADRA2C P18825 1/20 0.51
CHRM3 P20309 1/20 0.51
MAOA P21397 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6599893 0.90 KCNH2 (0.74) KCNH2HTR6DRD2HTR1BHTR2C
SCHEMBL2739092 0.90 KCNH2 (1.00) KCNH2HTR6DRD2HTR1BHTR2C
Hydrochloric Acid SCHEMBL27817823 0.89 KCNH2 (0.98) KCNH2HTR6DRD2HTR1BHTR2C
SCHEMBL8642973 0.89 KCNH2 (0.73) KCNH2HTR6DRD2HTR1BHTR2C
SCHEMBL6967113 0.88 KCNH2 (0.71) KCNH2HTR6DRD2HTR1BHTR2C
SCHEMBL6579238 0.84 KCNH2 (0.66) KCNH2HTR6DRD2HTR1BHTR2C
SCHEMBL6579260 0.82 KCNH2 (0.64) KCNH2HTR6DRD2HTR1BHTR2C
SCHEMBL6581472 0.82 KCNH2 (0.64) KCNH2HTR6DRD2HTR1BHTR2C
SCHEMBL9150576 0.82 KCNH2 (0.82) KCNH2HTR6DRD2HTR1BHTR2C
SCHEMBL9146788 0.82 KCNH2 (0.64) KCNH2HTR6DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575430-B1 PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE LUNDBECK & CO AS H (DK) 1998-08-05 EP disclosed
EP-0575429-B1 TREATMENT OF COGNITIVE DISORDERS LUNDBECK & CO AS H (DK) 1995-12-06 EP disclosed
US-5462948-A Treatment of addiction to drugs and substances of abuse H. LUNDBECK A/S (DK) 1995-10-31 US disclosed
US-5444073-A Administering 1-aryl-3-(4-piperidyl)-indole derivatives H. LUNDBECK A/S (DK) 1995-08-22 US disclosed
US-5439922-A Administering dopamine antagonists having reduced side effects H. LUNDBECK A/S (DK) 1995-08-08 US disclosed
EP-0533824-B1 PIPERIDYL-SUBSTITUTED INDOLES LUNDBECK & CO AS H (DK) 1994-11-09 EP disclosed